COMPARATIVE STUDY OF THE EFFICACY AND SAFETY OF МOXIFLOXACIN AND LEVOFLOXACIN THERAPY IN THE MANAGEMENT OF COMMUNITY-ACQUIRED PNEUMONIA.

Abstract

Community-acquired pneumonia is an urgent problem that requires effective treatment. For effective treatment of pneumonia, it is necessary to choose the right fluoroquinolone, taking into account the sensitivity of the pathogen and the pharmacokinetic characteristics of the drug. In this case, it is necessary to take into account the pronounced side effects and limitations of the use of these drugs. An important step is to determine the dosage and duration of treatment. The effectiveness and safety of treatment of pneumonia with fluoroquinolones is manifested in clinical and laboratory parameters. This article reviews a comparative study of moxifloxacin with levofloxacin in the treatment of community-acquired pneumonia, and compares the effectiveness and safety of these drugs.